A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
Clinical trial NCT04964518 · UNKNOWN
Trial details
- NCT number
- NCT04964518
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2024-07-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.